Ireland
--:--IST
Latest
Clinical Trials in Portugal / NCT07628686
Starting soon Not applicable

EMBRACE - From Vulnerable to Empowered: Implementation and Evaluation of a Multicomponent Program to Tackling Age-related Decline

NCT07628686 · tracked via the Priya Life Science Portugal tracker
Sponsor
University Fernando Pessoa
Phase
Not applicable
Started
2026-06-01
Last updated
2026-06-05

Condition(s) studied

Age-Related Cognitive Decline

Investigational drug(s) / intervention(s)

EMBRACE Intervention

EMBRACE Intervention: This intervention will last 12 months and will consist of four components. The nutritional intervention includes 5 individual sessions (at the beginning of the study and at 3, 6, 9, and 12 months) and 12 group sessions (1 per month) based on the Mediterranean diet, with support for oral health. Financial and digital literacy will be addressed in monthly sessions, covering topics such as retirement, investments, and fraud prevention. Cognitive and linguistic training will take place twice a week (80 sessions), with activities adapted through the COGWEB platform and support from a speech therapist. Physical training will also be conducted twice a week, including aerobic exercise, strength training, balance training, and dual-task training, with intensity adjusted using the Borg scale.

Study summary

EMBRACE is a randomized, controlled, multi-domain, blinded clinical trial involving 120 community-dwelling older adults at risk of cognitive decline, lasting 12 months. Participants are randomized 1:1 to either a multicomponent intervention group, including cognitive and language training, physical activity, nutritional counseling with oral health support, and financial and digital literacy education, or to a control group receiving regular health counseling. The trial evaluates the effects of the intervention on cognitive performance, quality of life, functionality, financial literacy, digital inclusion, and other health-related outcomes.

Eligibility

Sex
ALL
Min age
60 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: * MoCA ≥ 17 (Portuguese cutoff point to differentiate between mild cognitive impairment and dementia); * Bedside ≥ 20 for literate individuals or 12 for illiterate individuals. Exclusion Criteria: * Malignant diseases; * Diagnosed major depressive disorder; * Dementia/substantial cognitive decline (MoCA \< 17); * Symptomatic cardiovascular disease; * Revascularization within the last year; * Active malignancy; * Severe loss of vision, hearing, or communication; * Contraindications for physical activity; * Neuromuscular diseases; * Severe musculoskeletal pathology; * Inability to walk independently; * Neurological disease affecting language functions; * Simultaneous participation in any intervention trial.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University Fernando Pessoa Porto Porto District
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07628686 on ClinicalTrials.gov ↗ ← All trials in Portugal